Sphenopalatine Ganglion Stimulation for Chronic Headache Syndromes.
Journal
Progress in neurological surgery
ISSN: 1662-3924
Titre abrégé: Prog Neurol Surg
Pays: Switzerland
ID NLM: 0076033
Informations de publication
Date de publication:
2020
2020
Historique:
received:
20
06
2020
accepted:
21
06
2020
pubmed:
23
7
2020
medline:
15
9
2021
entrez:
23
7
2020
Statut:
ppublish
Résumé
Neuropathic facial pain is notoriously difficult to treat, regardless of its origin and duration. Since the first reported sphenopalatine ganglion blockade by Sluder in 1908, this ganglion has assumed an important role among the structures targeted for the treatment of facial pain. Recent years have witnessed the rise of neuromodulation over ablative procedures, including the development of an implantable stimulation device specially designed for use in the pterygopalatine fossa. Sphenopalatine ganglion stimulation has been demonstrated as effective and safe for refractory cluster headache, today the major indication for this therapy, but increasing evidence shows that the effect on the autonomic system and cerebral circulation could justify an even wider use of sphenopalatine ganglion stimulation for other chronic headache syndromes and vascular diseases.
Identifiants
pubmed: 32694255
pii: 000509619
doi: 10.1159/000509619
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
105-115Informations de copyright
© 2020 S. Karger AG, Basel.